The Immuno-Oncology Screening Library (96-Well) comprises 2 plates, housing over 90 cancer and immunology-related compounds in a 96-well Matrix tube rack format, presented as 10 mM stock solutions in DMSO. This library encompasses diverse immuno-oncology target modulators, such as adenosine, CCR, CXCR, and TLR agonists and antagonists, BTK, PI3K, VEGFR, and BRAF inhibitors, PD-1/PD-L1 interaction inhibitors, and HDAC inhibitors. Individual compound stability data is unavailable as supplied in the screening library. The library is regularly reviewed to incorporate new catalog introductions as research advances.